Roche beefs up diagnostic arm with another bet on faster, cheaper DNA sequencing

Roche today acquired Stratos Genomics, a Seattle-based developer of a new DNA technology designed to make genetic strands more easy to read. Roche said it will use the Stratos technology, alongside its existing efforts, to develop a nanopore sequencing device that can quickly and cheaply read patients’ DNA in clinics to diagnosis disease and assess the risk of developing one.